Hu CD[Author] - Search Results

Year	Number of Results
1986	1
1988	1
1989	2
1990	1
1993	1
1995	1
1996	2
1997	3
1998	4
1999	4
2000	3
2001	4
2002	1
2003	1
2004	2
2005	1
2006	5
2008	7
2009	5
2010	7
2011	4
2012	5
2013	4
2014	4
2015	6
2016	10
2017	4
2018	1
2019	5
2020	8
2021	9
2022	6
2023	3
2024	0

1

Visualization of interactions among bZIP and Rel family proteins in living cells using bimolecular fluorescence complementation.

Hu CD, Chinenov Y, Kerppola TK. Hu CD, et al. Mol Cell. 2002 Apr;9(4):789-98. doi: 10.1016/s1097-2765(02)00496-3. Mol Cell. 2002. PMID: 11983170 Free article.

2

PRMT5 promotes chemotherapy-induced neuroendocrine differentiation in NSCLC.

Shen Q, Liu Y, Deng X, Hu CD. Shen Q, et al. Among authors: hu cd. Thorac Cancer. 2023 Jun;14(18):1764-1773. doi: 10.1111/1759-7714.14921. Epub 2023 May 4. Thorac Cancer. 2023. PMID: 37140020 Free PMC article.

3

Natural Negative-Refractive-Index Materials.

Chen CY, Hsu MC, Hu CD, Lin YC. Chen CY, et al. Among authors: hu cd. Phys Rev Lett. 2021 Dec 3;127(23):237401. doi: 10.1103/PhysRevLett.127.237401. Phys Rev Lett. 2021. PMID: 34936775

4

PRMT5: a putative oncogene and therapeutic target in prostate cancer.

Beketova E, Owens JL, Asberry AM, Hu CD. Beketova E, et al. Among authors: hu cd. Cancer Gene Ther. 2022 Mar;29(3-4):264-276. doi: 10.1038/s41417-021-00327-3. Epub 2021 Apr 14. Cancer Gene Ther. 2022. PMID: 33854218 Free PMC article. Review.

5

JNJ-64619178 radiosensitizes and suppresses fractionated ionizing radiation-induced neuroendocrine differentiation (NED) in prostate cancer.

Pawar JS, Al-Amin MY, Hu CD. Pawar JS, et al. Among authors: hu cd. Front Oncol. 2023 Mar 7;13:1126482. doi: 10.3389/fonc.2023.1126482. eCollection 2023. Front Oncol. 2023. PMID: 36959798 Free PMC article.

6

Roles of neural stem cells in the repair of peripheral nerve injury.

Wang C, Lu CF, Peng J, Hu CD, Wang Y. Wang C, et al. Among authors: hu cd. Neural Regen Res. 2017 Dec;12(12):2106-2112. doi: 10.4103/1673-5374.221171. Neural Regen Res. 2017. PMID: 29323053 Free PMC article. Review.

7

Bimolecular fluorescence complementation (BiFC): a 5-year update and future perspectives.

Kodama Y, Hu CD. Kodama Y, et al. Among authors: hu cd. Biotechniques. 2012 Nov;53(5):285-98. doi: 10.2144/000113943. Biotechniques. 2012. PMID: 23148879 Free article. Review.

8

Fluorescence complementation: an emerging tool for biological research.

Shyu YJ, Hu CD. Shyu YJ, et al. Among authors: hu cd. Trends Biotechnol. 2008 Nov;26(11):622-30. doi: 10.1016/j.tibtech.2008.07.006. Epub 2008 Sep 17. Trends Biotechnol. 2008. PMID: 18804297 Review.

9

Neuroendocrine differentiation in prostate cancer: a mechanism of radioresistance and treatment failure.

Hu CD, Choo R, Huang J. Hu CD, et al. Front Oncol. 2015 Apr 14;5:90. doi: 10.3389/fonc.2015.00090. eCollection 2015. Front Oncol. 2015. PMID: 25927031 Free PMC article. Review.

10

Wnt/β-catenin signalling pathway in breast cancer cells and its effect on reversing tumour drug resistance by alkaloids extracted from traditional Chinese medicine.

Wu XL, Lin SG, Mao YW, Wu JX, Hu CD, Lv R, Zeng HD, Zhang MH, Lin LZ, Ouyang SS, Zhao YX. Wu XL, et al. Among authors: hu cd. Expert Rev Mol Med. 2023 Jun 19;25:e21. doi: 10.1017/erm.2023.16. Expert Rev Mol Med. 2023. PMID: 37332167 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

117 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

117 results

Results by year